Private equity-focused Lincoln International (LCLN Proposed) is the only big IPO on this week’s IPO Calendar. Lincoln is going public this week just as the SpaceX mania intensifies. Reuters reported late Friday that Elon Musk’s company might file to go public as soon as Wednesday, May 20. The expectation is that SpaceX might price its IPO on June 11 to trade June 12 – on the NASDAQ, according to Reuters.
Lincoln International, based in Chicago, is a global investment banking advisory firm that caters to private equity and private credit investors.
Lincoln’s IPO consists of 21.05 million shares at a price range of $18.00 to $20.00 to raise $400 million, if priced at the $19.00 mid-point of its range.
This is a New York Stock Exchange listing. It’s set to price Tuesday night, May 19, to trade Wednesday, May 20, on the NYSE.
Goldman Sachs and Morgan Stanley are leading the joint book-running team, which includes BMO Capital Markets, Citizens Capital Markets and Evercore ISI.
The company will use some of the IPO’s proceeds to pay off debt.
Lincoln International is profitable: It reported net income of $192.11 million on revenue of $809.4 million for the 12 months that ended March 31, 2026, according to the prospectus.
With just about everyone in “SpaceX Watch” mode – the small deals on this week’s IPO Calendar may have to work a little harder to get attention. There are two of these deals – Conexeu Sciences – a small NASDAQ Direct Listing – and Lannister Mining – a small NYSE-American Exchange (NYSE-AmEx) listing. There’s a handful of small carry-over deals as well this week.
Stay tuned.
(For more information about this company, please check the IPO Calendar and the individual IPO Profile found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.
Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.